Nos activités
Le Centre du sein Fribourg participe à des recherches cliniques internationales. De ce fait, il collabore activement à l’élaboration de médicaments innovants et au développement de nouvelles techniques pour soigner le cancer. Dans le cadre d’une recherche, le médecin peut proposer à sa patiente de participer à une étude clinique.
Les études en cours
TAXIS
Interventionnelle
Tailored Axillary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized phase III trial
CASCADE/DIALOGUE
Non-interventionnelle
Cascade Genetic Testing for Hereditary Breast Ovarian Cancer and Lynch Syndrome in Switzerland
PREcoopERA
Interventionnelle
A Window-of Opportunity trial of giredestrant +/- triptorelin vs. Anastrozol + triptorelin in premenopausal patients with ER-positive/HER2- negative early breast cancer
DESTINY
Non-interventionnelle
A prospective, non-interventional study (NIS) with trastuzumab deruxtecan for patients with HER2-low expressing unresecable and/or metastatic breast cancer accompanied by a disease registry of patients treated with conventional chemotherapy
MSD
MK 2870-012
Interventionnelle
A phase 3, randomized, open-label, study to compare the efficacy and safety of Adjuvant MK-2870 in combination with Pembrolizumab (MK-3475) versus treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and not achieve a pathological complete response (pCR) at surgery